Epigenica is a distinguished Swedish biotech company headquartered in Stockholm. As a spin-out from the prestigious Karolinska Institutet, Epigenica is committed to pushing the boundaries of science and technology in the field of epigenetics.

Epigenica excels in developing cutting-edge technology and tools that enable a deeper understanding of epigenetics, a field that explores the mechanisms by which genes are regulated and modified. With a firm focus on chromatin dynamics, their team of world-class scientists conducts groundbreaking research to enhance our grasp of this intricate process.

To accomplish their mission, Epigenica boasts a robust pipeline of innovative products and services. Spearheaded by their accomplished management team, including CEO Mohamad Takwa, CSO Simon Elsässer, and CTO Banushree Kumar, the company combines academic excellence with entrepreneurial vision. Mohamad, a strategic visionary, has previously founded and led four successful ventures, while Simon's expertise in biochemistry and biophysics stems from his research at prestigious institutions like Harvard University. Furthermore, Banushree's deep knowledge of molecular biology and genetics allows her to develop novel quantitative methods to unravel the mysteries of epigenetics.

Epigenica is at the forefront of epigenetic innovation, providing invaluable contributions to the scientific community and paving the way for advancements in medicine and biotechnology.